US OptionsDetailed Quotes

HIMS241108P35000

Watchlist

15.90
0.000.00%

15min DelayClose Nov 5 16:00 ET

0.00High0.00Low

Hims & Hers Health Stock Discussion

topcing

9 hours ago

$Hims & Hers Health (HIMS.US)$ great buy

10351974

11 hours ago

reclimb

Share Your Profit/Loss

frogoracletrading

Yesterday 09:50

$HIMS Support / Resistance Levels

Nice move up on earnings. Watch for the GAP to be tested tomorrow.
Larger Image: tradingview.com...
$Hims & Hers Health (HIMS.US)$

Trytosaveabit

Yesterday 06:24

Hmm

$Hims & Hers Health (HIMS.US)$ On conference call Hims & Hers Health Says It Plans to Bring Liraglutide the First Generic GLP-1 in the Market to the Platform in 2025?

Trytosaveabit

Yesterday 05:25

Nice

$Hims & Hers Health (HIMS.US)$ & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
Revenue of $401.6 million, up 77% year-over-year in Q3 2024
Net income of $75.6 million; Adjusted EBITDA of $51.1 million in Q3 2024
Subscribers grew to 2.0 million, up 44% year-over-year in Q3 2024
Raises full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million